Expression of inducible nitric oxide synthase in the liver is under the control of nuclear factor kappa B in concanavalin A-induced hepatitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 7 PT2, 2008, Pages

  Ma, Xue Lian ^a   Li, Yue Hua ^b   Gao, Jian Xin ^a   Li, Jing ^b   Guo, Lin ^b   Wu, Cui Zhen ^b  

^a SHANDONG UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Concanavalin A; Inducible nitric oxide synthase (iNOS); Inhibitor of kappa B (I B); Liver; Nuclear factor kappa B (NF B)

Indexed keywords

ALANINE AMINOTRANSFERASE; CONCANAVALIN A; EOSIN; HEMATOXYLIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; PYRROLIDINE DITHIOCARBAMATE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL TISSUE; ARTICLE; CELL SWELLING; CONTROLLED STUDY; ENZYME ACTIVITY; HEPATITIS; LIVER CELL; LIVER CELL NUCLEUS; LIVER CYTOSOL; LIVER FATTY DEGENERATION; LIVER HISTOLOGY; LIVER HOMOGENATE; LIVER NECROSIS; MALE; MOUSE; NONHUMAN; PHOTOMETRY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SPECTROSCOPY; WESTERN BLOTTING;

EID: 47649118012     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05083.x     Document Type: Article

References (25)

1. Tigers G, Hentschel L, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 1992 90 : 196 203.
2. Gantner F, Leist M, Wilhelm A et al. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995 21 : 190 98.
3. Trautwein C, Rakemann T, Brenner DA et al. Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumour necrosis factor in mice. Gastroenterology 1998 114 : 1035 45.
4. Baeuerle PA, Batlimore D. NF-κB: ten years after. Cell 1996 87 : 13 20.
5. Bohrer H, Qin F, Zimmermann T et al. Role of NF-κB in the mortality of sepsis. J. Clin. Invest. 1997 100 : 972 85.
6. Baldwin AS Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 1996 14 : 649 83.
7. Sass G, Koerber K, Bang R et al. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J. Clin. Invest. 2001 107 : 439 47.
8. Michel T, Xie QW, Nathan C. Molecular biological analysis of nitric oxide synthase. In : Feelish M, Stamler JS, eds. Methods of Nitric Oxide Research. Chichester : Wiley, 1996 161 75.
9. Geller DA, Lowensterin CJ, Shapiro RA et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. USA 1993 90 : 3491 5.
10. Laskin DL, Heck DE, Gardner CR et al. Distinct patterns of nitric oxide production in hepatic macrophages and endothelial cells following acute endotoxemia. J. Leukocyte. Biol. 1994 56 : 751 8.
11. Li J, Billiar TR. Nitric oxide. IV. Determinants of nitric oxide protection and toxicity in liver. Am. J. Physiol. 1999 276 : G1069 73.
12. Ganster RW, Taylor BS, Shao L et al. Complex regulation of man inducible nitric oxide synthase gene transcription by Stat I and NF-kappa B. Proc. Natl. Acad. Sci. USA 2001 98 : 8638 43.
13. Chu SC, Marks-Konczalik J, Wu HP et al. Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem. Biophys. Res. Commun. 1998 248 : 871 8.
14. Lauzurica P, Martinez-Martinez S, Marazuela M et al. Pyrrolidine dithiocarbamate protects mice from lethal shock induced by LPS or TNFα. Eur. J. Immunol. 1999 29 : 1890 900.
15. Cong B, Li SJ, Yao YX et al. Effect of Cholecystokinin octapeptide on tumor necrosis factor α transcription and nuclear factor kappaB activity induced by lipopolysaccharide in rat pulmonary interstitial macrophages. Word J. Gastroenterol. 2002 8 : 718 23.
16. Imose M, Nagaki M, Kimura K et al. Leflunomide protects from T-cell-mediated liver injury in mice through inhibition of nuclear factor kappa B. Hepatology 2004 40 : 1160 9.
17. Michel T, Feron O. Nitric oxide synthases: which, where, how and why? J. Clin. Invest. 1997 100 : 2146 52.
18. Nathan C. Inducible nitric oxide synthase: what difference does it make? J. Clin. Invest. 1997 100 : 2417 23.
19. Koziel MJ. Cytokines in viral hepatitis. Semin. Liver. Dis. 1999 19 : 157 69.
20. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J. Clin. Invest. 1997 100 : 2153 7.
21. Taylor BS, Alarcon LH, Billiar TR. Inducible nitric oxide synthase in the liver: regulation and function. Biochemistry 1998 63 : 766 81.
22. Macmicking J, Xie QW, Nanthan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997 15 : 323 50.
23. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992 6 : 3051 64.
24. Garcia-Monzon C, Majano PL, Zubia I et al. Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. J. Hepatol. 2000 32 : 331 8.
25. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxinitrite: the good, the bad, and ugly. Am. J. Physiol. 1996 271 : C1424 37.